FDA guidance seeks to better integrate patient priorities into drug development

Patient-centered drug development must start with an understanding of what patients feel is important about their condition and the attributes they’d like to see in medicines. A draft guidance FDA released Monday on Methods to Identify What is Important to Patients provides a road map for patients,